BiopharmaVantage acts as Advisor for AIM-listed Investors in their Investment into DNA Services Business

BiopharmaVantage is pleased to announce that it has acted as advisor for a top AIM listed investment company in its investment into a DNA based services business. The client, the investment company is a prestigious organisation involved in the funding and commercialisation of life sciences businesses in the UK.  The investee company is an emerging company that offers DNA based services to pharmaceutical, biotechnology and diagnostics companies and academic institutions.

United States Non-Invasive Prenatal Testing Market is likely to reach USD 1 Billion by 2023

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.
The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023”examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market.
The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.
The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.
Key Topics Covered in the Report
• United States Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States NIPT Test Market – Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• United States NIPT Test Market – Comparative Test Analysis
• United States NIPT Test Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market
Key Companies Covered in the Report are as follows:
• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics

United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.
The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023”examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market.
The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.
The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.
Key Topics Covered in the Report
• United States Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States NIPT Test Market – Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• United States NIPT Test Market – Comparative Test Analysis
• United States NIPT Test Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market
Key Companies Covered in the Report are as follows:
• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics
Contact:
Maria Rai
Sales Manager
sales@dpiresearch.com

DPI Research: Average Risk Actual & Potential NIPT Test Market

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.
The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023”examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market.
The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.
The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.
Key Topics Covered in the Report
• United States Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States NIPT Test Market – Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• United States NIPT Test Market – Comparative Test Analysis
• United States NIPT Test Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market
Key Companies Covered in the Report are as follows:
• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics

High Risk Actual & Potential NIPT Test Market

United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.
Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.
The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023”examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market.
The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.
The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.
Key Topics Covered in the Report
• United States Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 – 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 – 2023)
• United States NIPT Test Market – Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• United States NIPT Test Market – Comparative Test Analysis
• United States NIPT Test Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market
Key Companies Covered in the Report are as follows:
• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics
Contact
Maria Rai
Sales@dpiresearch.com

Global Dinotefuran Market to Maintain Healthy Growth By 2021

RT-logo-Pr

Dinotefuran is an insecticide of the neonicotinoid class developed by Mitsui Chemicals for control of insect pests such as aphids, whiteflies, thrips, leafhoppers, leafminers, sawflies, mole cricket, white grubs, lacebugs, billbugs,beetles, mealybugs, and cockroaches on leafy vegetables, in residential and commercial buildings, and for professional turf management.

This report provides detailed analysis of worldwide markets for Dinotefuran from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Dinotefuran market and further lays out an analysis of the factors influencing the supply/demand for Dinotefuran, and the opportunities/challenges faced by industry participants.

India Travelers Vaccines Market

Navi Mumbai, India: Market Reports on India present the latest report on “India Travelers Vaccines Market”,this report split by product types/category, covering many types with sales, revenue and market share for each type.

The Travelers Vaccines market size will be million (USD) in 2022 in India, from the million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) from 2016 to 2022.

In India market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players such as:
– GlaxoSmithKline/Novartis
– Sanofi Pasteur
– Pfizer
– Merck
– Sanofi Pasteur MSD
– CNBG
– Biokangtai

What’s Your Desert Island *** Toy?

                                               What’s Your Desert Island *** Toy?

 

43% of women picked toys that offer both clitoral and vaginal orgasm, 27% picked purely clitoral stimulating toys, 19% picked purely penetrative and 11% chose anal related toys.

 

The survey of 2,000 18-45 year olds by Bondage Bunnies, an online *** toy shop launched specifically for women asked women which toy they’d take to a desert island if they were stranded.

 

The most popular are…

 

  1. 25% rampant rabbit

Touring the UK this June is baby expert Alison Scott-Wright, coming to Liverpool, Manchester, Cardiff, Birmingham and Surrey.

For Immediate Release
Media Contact
Website link: www.magicsleepfairyroadshow.com
Link for tickets: magicsleepfairyroadshow.eventbrite.com

Touring the UK this June is baby expert Alison Scott-Wright, coming to Liverpool, Manchester, Cardiff, Birmingham and Surrey.